PUBMED FOR HANDHELDS

Journal Abstract Search


576 related items for PubMed ID: 16135679

  • 1. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
    Masoli M, Weatherall M, Holt S, Beasley R.
    Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
    [Abstract] [Full Text] [Related]

  • 2. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [Abstract] [Full Text] [Related]

  • 3. Clinical dose-response relationship of fluticasone propionate in adults with asthma.
    Masoli M, Weatherall M, Holt S, Beasley R.
    Thorax; 2004 Jan; 59(1):16-20. PubMed ID: 14694240
    [Abstract] [Full Text] [Related]

  • 4. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 5. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG, Lutter R, Jansen HM, van der Zee JS.
    Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
    [Abstract] [Full Text] [Related]

  • 6. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 7. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 9. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
    Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
    [Abstract] [Full Text] [Related]

  • 10. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 11. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
    Matz J, Emmett A, Rickard K, Kalberg C.
    J Allergy Clin Immunol; 2001 May; 107(5):783-9. PubMed ID: 11344343
    [Abstract] [Full Text] [Related]

  • 12. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 13. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
    Li HT, Zhang TT, Zhou H, Qu XJ, Wu WM, Huang J.
    Respiration; 2007 Oct 18; 74(1):33-43. PubMed ID: 17008769
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
    de Blic J, Ogorodova L, Klink R, Sidorenko I, Valiulis A, Hofman J, Bennedbaek O, Anderton S, Attali V, Desfougeres JL, Poterre M.
    Pediatr Allergy Immunol; 2009 Dec 18; 20(8):763-71. PubMed ID: 19239660
    [Abstract] [Full Text] [Related]

  • 16. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L, Humphries M, Du X, Wang L, Jiang J.
    Int J Clin Pract; 2005 Jul 15; 59(7):754-9. PubMed ID: 15963199
    [Abstract] [Full Text] [Related]

  • 18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 15; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr 15; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 20. Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
    Ernst P, Franssen E, Chan CK, Okell M, O'Byrne P, Bai T.
    Respir Med; 2008 Jan 15; 102(1):77-81. PubMed ID: 17904834
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.